Randomized, double-blind, placebo-controlled clinical trial to evaluate a probiotic preparation efficacy as adjuvant treatment in patients between 3 and 17 years old with atopic dermatitis

Ros Cervera, Gonzalo

Randomized, double-blind, placebo-controlled clinical trial to evaluate a probiotic preparation efficacy as adjuvant treatment in patients between 3 and 17 years old with atopic dermatitis

Identifiers

URI: http://hdl.handle.net/10952/6540

Files

Registro ATOP.PRO4.pdf (145.8 KB)

Publication date

2022-10

Authors

Ros Cervera, Gonzalo

Catholic University San Antonio of Murcia

Contributors

Sánchez Pellicer, Pedro

Metrics

Abstract

Randomized, double-blind, placebo-controlled clinical trial, to evaluate an oral probiotic effectiveness administered as adjuvant treatment for 12 weeks on the atopic dermatitis evolution in patients between 3 and 17 years old

Description

Randomized, double-blind, placebo-controlled clinical trial, to evaluate a probiotic preparation efficacy administered for 12 weeks on the evolution of atopic dermatitis patients between 3 and 17 years old A total of 60 patients diagnosed with atopic dermatitis will participate in the study, who will be randomized into two treatment groups in a 1:1 ratio (30 patients per group). The intervention groups are differentiated according to the treatment to be received: probiotic or placebo of similar appearance, along with standard therapy according to clinical guidelines. The 12 weeks of treatment are structured into 4 face-to-face visits: Visit 1 (initial; week 0), Visit 2 (week 4), Visit 3 (week 8) and Visit 4 (final; week 12).